🇺🇸 FDA
Patent

US 6312694

Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids

expired A61KA61K39/395A61K47/6835

Quick answer

US patent 6312694 (Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids) held by The Board of Regents of the University of Texas System expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
50
CPC classes
A61K, A61K39/395, A61K47/6835, A61K47/6849, A61K49/04